Donate to the Education and Research Fund Volunteer for the AAPM Find a Job or a Candidate AAPM Twitter AAPM on Facebook AAPM LinkedIn AAPM Flickr

March 14, 2013

March/April 2013 AAPM Newsletter - is now available in ‘PDF format’ on the AAPM website along with iPad and Android tablet versions. Some of you may have experienced difficulty reading with the FLIPBOOK version and hence the switch.

Apply Now for Grants & Fellowships
Applications are being accepted for the Research Seed Funding Grant and the AAPM/RSNA Fellowship for the Training of a Doctoral Candidate in the Field of Medical Physics. Learn more online.

This Issue


. CMS Announces Coverage Decision for PET

. March 6, 2013
. February 27, 2013
. February 20, 2013
. February 13, 2013
. February 6, 2013

. Radiation Oncology Program Accreditation Meeting: Online Evaluation System Available
. Hub and Spoke Residency Models Workshop: Online Evaluation System Available
. 3rd CT Dose Summit: Strategies for CT Scan Parameter Optimization: March 15 - 16, 2013; Phoenix, Arizona
. AAPM Spring Clinical Meeting: March 16 - 19, 2013; Phoenix, Arizona
. 2013 AAPM Summer School: June 16 - 20 , 2013; Colorado Springs, Colorado
. AAPM Annual Meeting & Exhibition: August 4 - 8, 2013; Indianapolis, Indiana
. Chapter Meetings

. NEW! Many older interviews with prominent medical physicists available in flash video for immediate viewing
. Call for Applications for AAPM Website Editor
. 2013 NIH Regional Seminar on Program Funding & Grants Administration in Baltimore, June 26-28
. Call for applications: Editors for Therapy and Imaging Physics for the journal Medical Physics
. Just released - Volume 2 of Controversies in Medical Physics
. News for ABR candidates


CMS Announces Coverage Decision for PET
The Centers for Medicare & Medicaid Services (CMS) has determined that, unless there is a specific national coverage determination, local Medicare Administrative Contractors (MACs) may determine coverage within their respective jurisdictions for positron emission tomography (PET) using radiopharmaceuticals for their Food and Drug Administration (FDA) approved labeled indications for oncologic imaging.

The effect of this decision is to remove the national non-coverage for FDA approved labeled oncologic uses of radiopharmaceuticals that are not more specifically determined nationally. Thus this decision does not change coverage for any use of PET using radiopharmaceuticals FDG (2-deoxy-2-[F-18] fluoro-D-Glucose (fluorodeoxyglucose)), NaF-18 (fluorine-18 labeled sodium fluoride), ammonia N- 13, or rubidium-82 (Rb-82). This decision does not prevent CMS from determining national coverage for any uses of any radiopharmaceuticals in the future, and if such determinations are made, a future determination would supersede local contractor determination.

See Full Article | Back to Top

The AAPM E-News is a collection of news and information that affects the field of Medical Physics.